scientific Sessions

CRISPR-Cas9 technology revolutionised the domain of endocrine research. By targeting genes involved in hormone production, action, and metabolism, researchers can now construct models that better resemble human disorders. The ability to rectify genetic abnormalities or change gene expression in endocrine tissues holds the possibility of innovative treatments for diabetes, thyroid diseases, and growth hormone deficits.

Wearable technology combined with artificial intelligence (AI) is changing the treatment of endocrine illnesses, including diabetes. Continuous glucose monitoring (CGM) systems, use technology that helps to provide real time data of blood glucose levels and has gotten more sophisticated with the integration of AI algorithms. The application of AI to analyse big datasets from wearable devices identifies patterns and predicts markers for a variety of endocrine diseases, allowing for earlier diagnosis and individualized treatment options.